LIPODYSTROPHY FREQUENCY ACCORDING TO INSULIN TREATMENT REGIMEN IN TYPE 2 DIABETIC PATIENTS: IS INSULIN INJECTION FREQUENCY MATTERS IN ANALOG INSULIN ERA?


Creative Commons License

Gunhan H., Elbasan O., Imre E., Yavuz D. G.

ACTA ENDOCRINOLOGICA-BUCHAREST, vol.18, no.2, pp.202-208, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.4183/aeb.2022.202
  • Journal Name: ACTA ENDOCRINOLOGICA-BUCHAREST
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE
  • Page Numbers: pp.202-208
  • Keywords: Diabetes Mellitus Type 2, insulin, lipodystrophy, lipohypertrophy, lipoatrophy, YOUNG-PATIENTS, RISK-FACTORS, LIPOHYPERTROPHY, LIPOATROPHY, PREVALENCE, SITES
  • Open Archive Collection: AVESIS Open Access Collection
  • Marmara University Affiliated: Yes

Abstract

Objectives. We aimed to determine lipodystrophy frequency according to insulin treatment regimen and insulin injection frequency in type 2 diabetic patients.